Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancerJohann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Breast Cancer Research : BCR|January 24, 2014
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trialVivien H C Bramwell, Alan B Tuck, Judith-Anne W Chapman, et al.
British Journal of Cancer|August 23, 2017
Circulating resistin levels and risk of multiple myeloma in three prospective cohortsLoredana Santo, Lauren R Teras, Graham G Giles, et al.
BMC Cancer|November 23, 2019
Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancerRemco J Molenaar, Jons W van Hattum, Iris S Brummelhuis, et al.
JNCI Cancer Spectrum|January 25, 2021
Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni SyndromeFarzana L Walcott, Ping-Yuan Wang, Christine M Bryla, et al.
JNCI Cancer Spectrum|September 6, 2021
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.
Journal of the Endocrine Society|December 22, 2017
Effects of Rapid Weight Loss on Systemic and Adipose Tissue Inflammation and Metabolism in Obese Postmenopausal WomenJosé O Alemán, Neil M Iyengar, Jeanne M Walker, et al.
Breast Cancer Research and Treatment|September 26, 2014
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trialAndrea DeCensi, Matteo Puntoni, Sara Gandini, et al.
Journal of Cancer Prevention|January 20, 2022
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: ReportAltaf Mohammed, Roderick H Dashwood, Sally Dickinson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatinDaniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancerJohann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Breast Cancer Research : BCR|January 24, 2014
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trialVivien H C Bramwell, Alan B Tuck, Judith-Anne W Chapman, et al.
British Journal of Cancer|August 23, 2017
Circulating resistin levels and risk of multiple myeloma in three prospective cohortsLoredana Santo, Lauren R Teras, Graham G Giles, et al.
BMC Cancer|November 23, 2019
Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancerRemco J Molenaar, Jons W van Hattum, Iris S Brummelhuis, et al.
JNCI Cancer Spectrum|January 25, 2021
Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni SyndromeFarzana L Walcott, Ping-Yuan Wang, Christine M Bryla, et al.
JNCI Cancer Spectrum|September 6, 2021
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.
Journal of the Endocrine Society|December 22, 2017
Effects of Rapid Weight Loss on Systemic and Adipose Tissue Inflammation and Metabolism in Obese Postmenopausal WomenJosé O Alemán, Neil M Iyengar, Jeanne M Walker, et al.
Breast Cancer Research and Treatment|September 26, 2014
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trialAndrea DeCensi, Matteo Puntoni, Sara Gandini, et al.
Journal of Cancer Prevention|January 20, 2022
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: ReportAltaf Mohammed, Roderick H Dashwood, Sally Dickinson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatinDaniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Pageof 18